Paper - WANFANG MED ONLINE

You Position: Home > Paper

Chromosomal microarray analysis of 339 fetuses with increased nuchal translucency and normal karyotype

( views:277, downloads:413 )

Author:: No author available

Journal Title:: Chinese Journal of Perinatal Medicine

Issue:: 8

DOI:: 10.3760/cma.j.issn.1007-9408.2019.08.009

Key Word:: 颈部透明带检查;微阵列分析;染色体缺失;染色体畸变;产前诊断;Nuchal translucency measurement;Microarray analysis;Chromosome deletion;Chromosome aberrations;Prenatal diagnosis

Abstract： Objective To explore the value of chromosome microarray analysis (CMA) in determining the genetic etiology of fetuses with increased nuchal translucency (NT) but normal karyotype. Methods Amniocentesis, karyotype analysis and CMA were performed to singleton pregnant women with increased fetal NT ( ≥ 3.0 mm) in early pregnancy (11+1-13+6 gestational weeks) at Shenzhen Maternity and Child Healthcare Hospital from March 2015 to December 2017. A total of 339 fetuses with normal G banding karyotype analysis were recruited retrospectively. Peripheral blood samples were collected for CMA in parents whose fetuses were detected with pathogenic copy number variations (CNVs) or variants of uncertain significance (VUS). Descriptive analysis was used for CMA results. Moreover, Pregnancy outcomes and postnatal conditions of fetuses with abnormal CNVs were followed up. Results Pathogenic CNVs, ranging from 68 kb to 12.636 Mb, were detected in 15 out of the 339 fetuses (4.4%) including four microduplications and 11 microdeletions. Among them, there were eight known microdeletion or microduplication syndromes (nine cases) including Williams-Beuren syndrome, 18p deletion syndrome,Wolf-Hirschhorn syndrome, 22q11 duplication syndrome, 16p11.2 deletion syndrome, 17p13.3 duplication syndrome, 16p11.2 duplication syndrome (one case respectively) and DiGeorge syndrome/velocardiofacial syndrome (two cases). Of the 11 fetuses with VUS, five cases originated from parents with normal phenotype and the identified VUS were benign and the rest six were de novo mutations[1.8%(6/339)]. Of the 15 fetuses with pathogenic CNVs, one was lost to follow-up, four were live born and two of which was found to be growth retardation at the age of two. Among the 11 fetuses with VUS, nine were live born and no abnormality was reported in any cases at one year old. Conclusions For fetus with increased NT and normal karyotype, CMA is able to identify chromosomal microdeletion/microduplication that are not recognized by conventional karyotyping analysis, and may play an important role in prenatal diagnosis and genetic counseling.

Reference

[1]Rosenfeld JA,Girirajan S,Cooper G.A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay.[J].2010,42(3).
[2]Petersen,O.B.,Vogel,I.,Ekelund,C.,etc.Potential diagnostic consequences of applying non-invasive prenatal testing: Population-based study from a country with existing first-trimester screening[J].2014,43(3).
[3]Hastings PJ,Lupski JR,Rosenberg SM.Mechanisms of change in gene copy number.[J].2009,10(8).
[4]Ryo,Kimura,Yuko,Ishii,Kiyotaka,Tomiwa,etc.Williams-Beuren Syndrome as a Potential Risk Factor for Burkitt Lymphoma.[J].2018,9.
[5]Souka, A. P.,von Kaisenberg, C. S.,Hyett, J. A.,etc.Increased nuchal translucency with normal karyotype[J].2005,192(4).
[6]?yr?s,O.,Tikkanen,M.,Eronen,M.,etc.Increased nuchal translucency and pregnancy outcome: A retrospective study of 1063 consecutive singleton pregnancies in a single referral institution[J].2013,33(9).
[7]Ronald I. Wapner,Christa Lese Martin,Brynn Levy,etc.Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis[J].2012,367(23).
[8]Mikhail,F.M.,Burnside,R.D.,Rush,B.,etc.The recurrent distal 22q11.2 microdeletions are often de novo and do not represent a single clinical entity: A proposed categorization system[J].2014,16(1).
[9]Fernstrom M,Ohrner Y,Wentzel C.Clinical variability of the 22q11.2 duplication syndrome.[J].2008,51(6).
[10]Brian Chung,Bridget A Fernandez,Rosanna Weksberg,etc.Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder[J].2010,47(3).
[11]Amanda, Przybylska-Kruszewska,Anna, Kutkowska-Ka?mierczak,Amanda, Krzywdzińska,etc.[17p13.3 Duplication as a Cause of Psychomotor Developmental Delay in an Infant - a Further Case of a New Syndrome].[J].2016.
[12]Barbara, Vona,Indrajit, Nanda,Cordula, Neuner,etc.Terminal chromosome 4q deletion syndrome in an infant with hearing impairment and moderate syndromic features: review of literature.[J].2014,15.
[13]Paylor R,Glaser B,Mupo A,etc.Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome[J].2006,103(20).
[14]Lin Li,Linhuan Huang,Shaobin Lin,etc.Discordant phenotypes in monozygotic twins with 16p11.2 microdeletions including the SH2B1 gene[J].2017,173(8).
[15]Masato Ikawa,Kiyoe Ura,Keisuke Nimura,etc.A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome[J].2009,460(7252).
[16]Cormican,P.,Pato,C.,Kirov,G.,etc.CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1[J].2014,23(6).
[17]Owen MJ,O'Donovan MC,Craddock N.Microduplications of 16p11.2 are associated with schizophrenia.[J].2009,41(11).
[18]Dijkhuizen T,Kok K,van Ravenswaaij Arts CM,etc.Practical guidelines for interpreting copy number gains detected by high-resolution array in routine diagnostics.[J].2012,20(2).
[19]Stalker H,Coe BP,Rosenfeld JA,etc.A copy number variation morbidity map of developmental delay.[J].2011,43(9).
[20]Jeffrey W Innis,Wenbo Xu,Ramaswamy K Iyer,etc.Chromosome 4q deletion syndrome: narrowing the cardiovascular critical region to 4q32.2-q34.3.[J].2012,158A(3).
[21]Bilardo, Caterina M.,Pajkrt, Eva,Bakker, Merel.Increased nuchal translucency with normal karyotype and anomaly scan: What next?[J].2014,28(3).
[22]Barbara Pertl,Maj A. Hulten,Seema Dhanjal.Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR[J].2003,126(3).
[23]Cirigliano V,Bui TH,Faas BH.Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies.[J].2011,16(2).
[24]R, Chaoui,K D, Kalache,K S, Heling,etc.Absent or hypoplastic thymus on ultrasound: a marker for deletion 22q11.2 in fetal cardiac defects.[J].2002,20(6).
[25]Yao-Shan Fan,Linbo Yu,Sandra Donkervoort,etc.Genotype-phenotype analysis of 4q deletion syndrome: proposal of a critical region.[J].2012,158A(9).
[26]Huihui Sun,Naijun Wan,Xinli Wang,etc.Genotype-Phenotype Analysis, Neuropsychological Assessment, and Growth Hormone Response in a Patient with 18p Deletion Syndrome[J].2018,154(2).
[27]Amalia Garcia-Santiago, Fe,Martinez-Glez, Victor,Santos, Fernando,etc.Analysis of Invdupdel(8p) Rearrangement: Clinical, Cytogenetic and Molecular Characterization[J].2015,167A(5).
[28]Lin Shaobin,Shi Shanshan,Zhou Yi,etc.Intrauterine phenotypic features associated with 16p11.2 recurrent microdeletions[J].2018,38(6).
[29]Manning M,Hudgins L.Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities.[J].2010,12(11).